About Vamstar
Vamstar is a company based in London (United Kingdom) founded in 2019 by Richard Freeman. Vamstar has raised $11.2 million across 3 funding rounds from investors including Celltrion, AICapital and Dutch Founders Fund. Vamstar offers products and services including Polaris, Pricing Co-Pilot, Data Orchestration, and Pharma Net Price Tracker. Vamstar operates in a competitive market with competitors including Tomorrow Health, SkyCell, Zoplar, AA Medical Store and Marken, among others.
- Headquarter London, United Kingdom
- Founders Richard Freeman
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vamstar Limited
- Date of Incorporation 12 Sep, 2019
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.2 M (USD)
in 3 rounds
-
Latest Funding Round
$9.5 M (USD), Series A
May 11, 2022
-
Investors
Celltrion
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vamstar
Vamstar offers a comprehensive portfolio of products and services, including Polaris, Pricing Co-Pilot, Data Orchestration, and Pharma Net Price Tracker.
Offers data science tools for tendering and pricing optimization.
AI system for enhancing pharmaceutical tender bidding strategies.
Platform for processing and analyzing market data in life sciences.
Monitors net prices and revenue in pharmaceutical markets.
People of Vamstar
Unlock access to complete
Funding Insights of Vamstar
Vamstar has successfully raised a total of $11.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $9.5 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $9.5M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series A - Vamstar | Valuation | AIC , Dutch Founders Fund | |
| Dec, 2020 | Amount | Seed - Vamstar | Valuation | b2venture | |
| Jan, 2020 | Amount | Seed - Vamstar | Valuation |
investors |
Investors in Vamstar
Vamstar has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Celltrion, AICapital and Dutch Founders Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI-first companies are supported through venture capital investments.
|
Founded Year | Domain | Location | |
|
Early-stage investing and founder support services are offered globally by Antler.
|
Founded Year | Domain | Location | |
|
Venture capital is provided to innovative startups by b2venture.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vamstar
Financial Statements - Vamstar
Vamstar Comparisons
Competitors of Vamstar
Vamstar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tomorrow Health, SkyCell, Zoplar, AA Medical Store and Marken, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of an online store for healthcare products
|
|
| domain | founded_year | HQ Location |
Temperature-controlled containers for pharmaceutical transport are provided.
|
|
| domain | founded_year | HQ Location |
B2B medical supply platform that simplifies procurement for hospitals and clinics by offering a wide range of medical devices, equipment, and consumables
|
|
| domain | founded_year | HQ Location |
New and pre-owned medical equipment is retailed online.
|
|
| domain | founded_year | HQ Location |
Provider of supply chain logistics solutions and services for pharma and medical devices industry
|
Frequently Asked Questions about Vamstar
Vamstar was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Vamstar is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Praful Mehta is the current CEO of Vamstar.
Vamstar is a funded company, having raised a total of $11.2M across 3 funding rounds to date.
Vamstar was founded in 2019 in London, United Kingdom, focusing on healthcare procurement. An AI-based platform is utilized for managing purchases, where natural language processing and deep learning extract data from websites, registries, and documents. Interactive dashboards and reports are generated to analyze buyer and competitor behaviors, aiding commercial decisions. AI is employed to match procurement needs with supplier capabilities.
Vamstar's top competitors include Tomorrow Health, SkyCell and Zoplar.
Vamstar offers Polaris, Pricing Co-Pilot, Data Orchestration, and Pharma Net Price Tracker.
Vamstar has 7 investors. Key investors include Celltrion, AICapital, Dutch Founders Fund, Antler, and Mirae Asset Global Investments.
The valuation of Vamstar is $32.31M as of May 2022.